Associate Medical Director
Department of Pediatrics,
Section of Hematology-Oncology and
Department of Medicine,
Section of Cardiovascular Sciences,
Thrombosis Research Section
Baylor College of Medicine
6701 Fannin Street, Ste. 1510
Houston, TX 77030
Dr. Mona Shah’s clinical interests include: general hematology, thalassemia, immune hematology, disorders of hemostasis and thrombosis, sickle cell anemia and other hemoglobinopathies.
She is board certified by the American Board of Pediatrics in pediatrics and pediatric hematology/oncology.
Dr. Mona D. Shah’s current research interests include clinical and translational projects in hemostasis and thrombosis. She is currently the Principal and/or Co-Investigator of several clinical trials evaluating hemostatic/thrombotic therapeutic agents, including Factor XIII, dalteparin (Fragmin®), dabigatran (Pradaxa®), etc.
Her previous research has involved a number of basic science and translational research projects to evaluate the roles of tissue factor-bearing microparticles in the pathophysiology of various hematologic and oncologic disorders (e.g., idiopathic thrombocytopenic purpura, hemophilia, deep venous thrombosis. Her work involved optimizing methods of isolation, detection, and analysis of plasma microparticle levels and their associated procoagulant activity, as key mediators of hemostasis and thrombosis. In order to address parameters that significantly affect circulating microparticle measurements, Dr. Shah developed a novel assay, where microparticles are measured from whole blood with far less manipulation of the original sample.
MD, University of Maryland School of Medicine
MS, Clinical Investigation, Baylor College of Medicine
Graduate Certificate in Healthcare Management, Rice University, Jesse H. Jones Graduate School of Business
Residency, Rainbow Babies and Children’s Hospital, University Hospitals of Cleveland
Fellowship, Pediatric Hematology/Oncology, Baylor College of Medicine
Member, American Society of Hematology
Member, American Society of Pediatric Hematology-Oncology
Member, Hemophilia Thrombosis Research Society
Member, International Society for Thrombosis and Hemostasis
Member, National Hemophilia Foundation
Hemophilia & Thrombosis Center
Sickle Cell Program